GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SL Science Holding Limited Ordinary Shares SLBT · USD

US listing · 🇺🇸 United States

Compare

0.98

+4.31%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About SL Science Holding Limited Ordinary Shares

Its shares trade under the ticker SLBT. It has been listed since 15 June 2026. In the fiscal year to 31 December 2025, it reported revenue of $2.2m and a net loss of $3.8m. At that date it held total assets of $2.8m and shareholders' equity of $2.3m.

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Listed since
15 Jun 2026
Employees
20
Website
sl-bio.com ↗
Head office
11/F, NO. 479 CHONGYANG ROAD, TAIPEI CITY, 115010
Incorporated in
E9
Classification
Biological Products, (No Diagnostic Substances)
Filer status
<br>Emerging growth company

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • SL Science Holding Limited manufactures cosmetic skin care products including SL bio's milk-derived exosome essence.
  • The company offers research services in armed T-cells and gamma delta T-cells.
  • SL Science Holding Limited provides the MilkExo concentrate series as part of its product line.

Weaknesses

  • The company has only 20 employees, indicating a small operational scale.
  • SL Science Holding Limited is scheduled for an IPO in June 2026, which may indicate limited current market presence.
  • The company's sector and industry are listed as unknown, suggesting a lack of clear market positioning.

Opportunities

  • The company's focus on milk-derived exosome essence presents a niche market opportunity in cosmetic science.
  • Research services in citrus reticulata (tangerine) extract could expand into new product segments.
  • The company's base in Taipei, Taiwan, may provide access to regional markets in Asia.

Threats

  • The company's unknown sector and industry may hinder strategic partnerships and market entry.
  • The upcoming IPO in June 2026 could face market volatility affecting its valuation.
  • The company's reliance on a limited product range, such as SL bio's tangerine-derived extract, poses concentration risk.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.